Pamiron, Jacqueline .
HRN: 22-66-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2023
CEFUROXIME 500MG (TAB)
05/27/2023
06/02/2023
PO
500mg
BID
Post Episiorrhaphy
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes